Tocqueville Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,000
| Closed | -$390K | – | 719 |
|
|
2020
Q3 | $390K | Hold |
4,000
| – | – | 0.01% | 536 |
|
|
2020
Q2 | $624K | Hold |
4,000
| – | – | 0.01% | 458 |
|
|
2020
Q1 | $577K | Hold |
4,000
| – | – | 0.01% | 430 |
|
|
2019
Q4 | $818K | Sell |
4,000
-2,215
| -36% | -$453K | 0.01% | 479 |
|
|
2019
Q3 | $499K | Buy |
6,215
+25
| +0.4% | +$2.01K | 0.01% | 563 |
|
|
2019
Q2 | $584K | Buy |
+6,190
| New | +$584K | 0.01% | 565 |
|